Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

APMDApnimed, Inc.

Nasdaq · CIK 0001745648
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts160

Identity from submissions API

NameApnimed, Inc.
CIK0001745648
TickersAPMD
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN821910611
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-500-8880
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
39 JOHN F. KENNEDY STREET, 4TH FLR.
CAMBRIDGE
MA
02138
MA
Mailing address
39 JOHN F. KENNEDY STREET, 4TH FLR.
CAMBRIDGE
MA
02138
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

61 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-463732 005-95843 261562323 34 7402
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-004928 005-95843 261561186 34 33405
2026-11-16 10-Q 10-Q 0001193125-26-462185 001-43422 261555588 34 15758385 1 1
2026-11-16 8-K 8-K 2.02,9.01 0001193125-26-462171 001-43422 261555562 34 594429 1 1
2026-11-13 10-Q/A 10-Q/A 0001193125-26-460871 001-43422 261553600 34 16343851 1 1
2026-11-13 8-K 8-K 4.02 0001193125-26-460864 001-43422 261553546 34 192776 1 1
2026-11-04 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000947871-26-000976 005-95843 261520302 34 6673
2026-09-08 S-8 S-8 0001193125-26-385357 333-298803 261365858 33 514853 1 1
2026-09-08 10-Q 10-Q 0001193125-26-385356 001-43422 261365850 34 15439916 1 1
2026-09-08 8-K 8-K 2.02,9.01 0001193125-26-385355 001-43422 261365845 34 619128 1 1
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-340067 005-95843 261253539 34 228498
2026-08-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-092032 005-95843 261249291 34 19315
2026-08-05 4 FORM 4 0000905148-26-003483 21504
2026-08-05 4 xslF345X06/ownership.xml 0000919574-26-004812 28730
2026-08-03 4 4 0001193125-26-330510 14025
2026-08-03 4 4 0001193125-26-330505 18573
2026-08-03 4 4 0001193125-26-330508 18767
2026-08-03 4 4 0001193125-26-330504 18756
2026-08-03 4 4 0001193125-26-330507 21784
2026-08-03 4 4 0001193125-26-330503 9752
2026-08-03 4 4 0001193125-26-330506 62623
2026-08-03 4 4 0001193125-26-330502 42747
2026-08-03 8-K 8-K 5.03,9.01 0001193125-26-330509 001-43422 261232678 34 324953
2026-07-31 S-8 S-8 0001193125-26-328744 333-297900 261229112 33 403288 1 1
2026-07-31 424B4 424B4 0001193125-26-328422 333-297377 261228347 33 25469556
2026-07-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002498 333-297377 261225217 33 1722
2026-07-30 3 FORM 3 0000905148-26-003420 8641
2026-07-30 S-1MEF S-1MEF 0001193125-26-326515 333-297849 261224998 33 267788 1 1
2026-07-30 3 xslF345X06/ownership.xml 0000919574-26-004695 17835
2026-07-30 3 3 0001193125-26-326266 25447
2026-07-30 3 3 0001193125-26-326255 17018
2026-07-30 3 3 0001193125-26-326223 15862
2026-07-30 3 3 0001193125-26-326218 19206
2026-07-30 3 3 0001193125-26-326210 17714
2026-07-30 3 3 0001193125-26-326204 16196
2026-07-30 3 3 0001193125-26-326202 16701
2026-07-30 3 3 0001193125-26-326201 6037
2026-07-30 3 3 0001193125-26-326188 33149
2026-07-30 CERT APMD_8A_Cert_0001745648.pdf 0001354457-26-000743 001-43422 261221650 34 116309
2026-07-29 8-A12B 8-A12B 0001193125-26-322198 001-43422 261214009 34 31643
2026-07-27 S-1/A S-1/A 0001193125-26-316811 333-297377 261202787 33 27769697 1 1
2026-07-10 S-1 S-1 0001193125-26-300909 333-297377 261168893 33 33022475 1 1
2026-06-01 DRS/A filename1.htm 0001193125-26-249229 377-07317 261046832 33 10531859
2026-04-22 DRS/A filename1.htm 0001193125-26-167732 377-07317 26881044 33 11050672
2026-03-27 D xslFormDX01/primary_doc.xml 06b 0001745648-26-000001 021-578027 26800665 33 14066
2026-02-17 DRS/A filename1.htm 0001193125-26-054701 377-07317 26641590 33 7393320
2025-12-08 D/A xslFormDX01/primary_doc.xml 06b 0001745648-25-000005 021-558476 251555677 33 14069
2025-10-01 D/A xslFormDX01/primary_doc.xml 06b 0001745648-25-000004 021-558476 251362845 33 13997
2025-09-24 D xslFormDX01/primary_doc.xml 06b 0001745648-25-000003 021-558476 251335637 33 13912
2025-04-24 D xslFormDX01/primary_doc.xml 06b 0001879785-25-000026 021-544389 25865263 33 13076
2024-07-01 DRS filename1.htm 0000950123-24-006348 377-07317 241091238 33 12840238
2023-11-08 D xslFormDX01/primary_doc.xml 06b 0001745648-23-000001 021-496807 231387477 33 12053
2022-12-23 D xslFormDX01/primary_doc.xml 06b 0001745648-22-000003 021-468579 221483979 33 11992
2022-11-01 D/A xslFormDX01/primary_doc.xml 06b 0001745648-22-000002 021-445175 221350061 33 12851
2022-05-10 D xslFormDX01/primary_doc.xml 06b 0001745648-22-000001 021-445175 22909699 33 12004
2021-03-25 D xslFormDX01/primary_doc.xml 06b 0001745648-21-000001 021-393539 21771985 33 10006
2020-04-07 D xslFormDX01/primary_doc.xml 06b 0001745648-20-000001 021-364430 20778689 33 9957
2019-08-07 D/A xslFormDX01/primary_doc.xml 06b 0001745648-19-000008 021-316175 191006115 33 9743
2019-01-10 D/A xslFormDX01/primary_doc.xml 06b 0001745648-19-000001 021-316175 19519575 33 9756
2018-08-09 D/A xslFormDX01/primary_doc.xml 06b 0001745648-18-000002 021-316175 181003994 33 9757
2018-07-06 D xslFormDX01/primary_doc.xml 06b 0001745648-18-000001 021-316175 18942210 33 9617

Latest XBRL company facts

One latest value per concept from companyfacts (160 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 41.63M 2026-11-10 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
ffd NetFeeAmt NetFeeAmt USD 9,145.67 2026-09-08 S-8 2026-09-08 0001193125-26-385357
ffd TtlFeeAmt TtlFeeAmt USD 9,145.67 2026-09-08 S-8 2026-09-08 0001193125-26-385357
ffd TtlOfferingAmt TtlOfferingAmt USD 66.22M 2026-09-08 S-8 2026-09-08 0001193125-26-385357
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-08 S-8 2026-09-08 0001193125-26-385357
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-30 S-1MEF 2026-07-30 0001193125-26-326515
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 15.07M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 588,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 5.45M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 71,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 517.97M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 6.27M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 32.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap Assets Assets USD 371.49M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AssetsCurrent Assets, Current USD 360.96M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap AssetsHeldForSaleLongLivedFairValueDisclosure Assets Held-for-sale, Long Lived, Fair Value Disclosure USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 351.83M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 352.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 310.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 36.50M 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 11.01M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 41.63M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 41.63M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 245.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 39.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 35.00M 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 3.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 39.33M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.1 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 2.65M 2026-08-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 39.30M 2026-08-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 35.00M 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 4.78M 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap DeferredRevenue Deferred Revenue USD 17.30M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 17.30M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 93.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DepositLiabilityCurrent Deposit Liability, Current USD 57.10M 2026-04-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap Depreciation Depreciation USD 20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share USD/shares 6.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share USD/shares 4.88 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 85.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 13 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 9.63 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 6.29M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 40.77M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EquityMethodInvestmentAggregateCost Equity Method Investment, Aggregate Cost USD 26.90M 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EquityMethodInvestmentRealizedGainLossOnDisposal Equity Method Investment, Realized Gain (Loss) on Disposal USD 85.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap EquityMethodInvestments Equity Method Investments USD 34.80M 2024-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap FairValueOptionCreditRiskGainsLossesOnAssets Fair Value, Option, Credit Risk, Gains (Losses) on Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 41.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 81.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 81.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares 6.46 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares 4.75 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -2.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 17.21 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 2.57 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 82.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -371,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -95.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncreaseDecreaseInDepositsOutstanding Increase (Decrease) in Deposits Outstanding USD 57.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -186,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 4.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 5.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 340,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 4.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 2.95M 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 21.14M 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 752,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 78,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 27,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 328,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 319,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 65,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap Liabilities Liabilities USD 86.73M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 371.49M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap LiabilitiesCurrent Liabilities, Current USD 36.96M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 39.06M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 269.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 99.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -59.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 164.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 193.65M 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 192.34M 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic USD 81.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted USD 80.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic USD 82.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted USD 82.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 57.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OciEquityMethodInvestmentAfterTax OCI, Equity Method Investment, after Tax USD 62.20M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OperatingExpenses Operating Expenses USD 75.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 24.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 183,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 687,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 273,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 414,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 652,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.081 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 166,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 24,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OtherIncome Other Income USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -2.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PaymentsForRent Payments for Rent USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 6.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 249.52M 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 6.66M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.88M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 21.90M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 25.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 48.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 245.94M 2026-08-03 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 815,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 150.00M 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ProceedsFromRepurchaseOfRedeemablePreferredStock Proceeds from (Repurchase of) Redeemable Preferred Stock USD 248.75M 2026-08-03 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 100.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 79,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 117,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 46,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 29.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 352.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 500,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -233.21M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap Revenues Revenues USD 99.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap RoyaltyExpense Royalty Expense USD 8.60M 2018-06-19 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap SeveranceCosts1 Severance Costs USD 300,000 2026-01-01 2026-06-30 2026 Q2 10-Q/A 2026-11-13 0001193125-26-460871
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 8.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 4.63M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 284.76M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 245.94M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 198.90M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 18,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 70,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 249.52M 2026-08-03 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 29.56M 2026-08-03 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 28.52M 2026-08-03 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 28.52M 2026-08-03 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 16.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 12.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462185

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →